“This accolade underscores our commitment to advancing several United Nations Sustainable Development Goals, including promoting good health and well-being and reducing inequalities,” said Kevin Koh, founder and CEO of Vivo Surgical.
“Winning this prestigious global award sends a powerful message to healthcare organizations, funders and investors, opening doors for enhanced collaboration and development opportunities. This recognition will also further bolster our IP portfolio and fuel greater innovation in our technological advancements,” he added.
“They were one of our WIPO-IPOS IP for Innovation Award winners in 2022, and we’re glad they have gained yet another prestigious accolade, thanks to their innovation and strategic use of IP,” said a representative from the Intellectual Property Office of Singapore (IPOS).